Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache	brain disorder, central nervous system disorder, cluster headache syndrome, headache disorder, hypnic headache, nervous system disorder, trigeminal autonomic cephalalgia	Recruiting	Phase 3	2024-11-19		NCT03944876

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Catholic University of Valencia	1
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta	55
Norwegian University of Science and Technology	114
PRAXISKLINIK ULMENHOF	1
St. Olavs Hospital	167
University College, London	222

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Neurology, University Clinic Hospital. Catholic University of Valencia	Valencia	Spain	1
Fondazione IRCCS Istituto Neurologico Carlo Besta (CBNI)	Milan	Italy	1
National Hospital of Neurology and Neurosurgery, University College of London	London	United Kingdom	1
Praxisklinik Ulmenhof	Hamburg	Germany	1
St Olavs Hospital	Trondheim	Norway	21